Genenta Science, Amgen, Ospedale San Raffaele deal

Genenta, San Raffaele and Amgen partnered to evaluate myeloid-targeted hematopoietic stem cell (HSC) therapies to treat cancer. The partners will use Genenta’s HSC platform, which it licensed from San...